{"transactions":[{"id":1295270,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T21:51:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were fully vested as of January 2, 2025, the grant date."}],"balance_after":75000,"derivative":{"exercise_price":1.31,"exercise_date":"2025-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-25-006569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025006569/ownership.xml","form_type":"4"}},{"id":1298471,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-01-21T21:58:50.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":11626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect the Issuer's 1:12 reverse stock split on August 12, 2024."}],"balance_after":26370,"source":{"system":"sec-edgar","filing":"0001213900-25-005051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025005051/ownership.xml","form_type":"4"}},{"id":1506546,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:22:13.000Z","date":"2024-05-16","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F5","text":"15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs."},{"field":"shares","element":"transactionShares","label":"F5","text":"15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-24-045707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045707/ownership.xml","form_type":"4"}},{"id":1506545,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:22:13.000Z","date":"2024-04-12","kind":"exercise","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F4","text":"60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs."},{"field":"shares","element":"transactionShares","label":"F4","text":"60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs."}],"balance_after":15000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-24-045707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045707/ownership.xml","form_type":"4"}},{"id":1506544,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T00:22:13.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock."}],"balance_after":75000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-24-045707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045707/ownership.xml","form_type":"4"}},{"id":1506543,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-22T00:22:13.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.223,"value":3345.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"15,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Tyrone Miller owned 161,928 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Tyrone Miller owned a total of 176,928 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"15,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Tyrone Miller owned 161,928 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Tyrone Miller owned a total of 176,928 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"15,000 shares underlying the RSUs were settled on May 16, 2024 (the \"5/24 Shares\"). Tyrone Miller owned 161,928 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Tyrone Miller owned a total of 176,928 shares of common stock."}],"balance_after":176928,"source":{"system":"sec-edgar","filing":"0001213900-24-045707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045707/ownership.xml","form_type":"4"}},{"id":1506542,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2024-05-22T00:22:13.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0.2668,"value":16008.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Tyrone Miller was granted a total of 75,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 60,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Tyrone Miller owned 101,928 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Tyrone Miller owned a total of 161,928 shares of common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Tyrone Miller was granted a total of 75,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 60,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Tyrone Miller owned 101,928 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Tyrone Miller owned a total of 161,928 shares of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Tyrone Miller was granted a total of 75,000 restricted stock units (\"RSUs\") on November 21, 2023 that were fully vested as of the grant date. 60,000 shares underlying the RSUs were settled on April 12, 2024 (the \"4/24 Shares\"). Tyrone Miller owned 101,928 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Tyrone Miller owned a total of 161,928 shares of common stock."}],"balance_after":161928,"source":{"system":"sec-edgar","filing":"0001213900-24-045707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024045707/ownership.xml","form_type":"4"}},{"id":1830712,"issuer":{"id":8389,"kind":"organization","name":"60 DEGREES PHARMACEUTICALS, INC."},"owners":[{"id":83893,"kind":"person","name":"MILLER TYRONE","position":1,"cik":"0001976962","reported_name":"MILLER TYRONE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2023-07-12T18:54:20.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Non-Qualified Stock Option granted pursuant that certain Employment Agreement, dated January 1, 2023, between the Issuer and the Reporting Person, subject to terms and conditions of the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Vests in 12,000 increments on the last day of each fiscal quarter (March 31st, June 30th, September 30th, December 31st)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Date indicated is the date of grant."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Vests in 12,000 increments on the last day of each fiscal quarter (March 31st, June 30th, September 30th, December 31st)."}],"balance_after":240000,"derivative":{"exercise_price":5.3,"exercise_date":"2023-07-12","expiration_date":"2028-07-12","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001575872-23-001135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000157587223001135/ownership.xml","form_type":"4"}}]}